#National Cancer Institute

An ongoing study is assessing pediatric and young adult cancers that did not respond to initial treatments.

Even small changes in physical fitness can make it possible for people to maintain their quality of life as cancer progresses.

Given the long timeline needed for human studies, people today should not expect this technology to be proven and fully approved for years.

“The simplicity of this approach means that it is promising to take forward” to a human vaccine, researchers say.

The genomic research field has been trending towards more data points, so the emergence of low-coverage sequencing.

Bintrafusp shrank tumors in over a third of patients with cervical, anal or head and neck cancer.

The study suggests that increasing T cells’ exposure to potassium may make cancer immunotherapies more effective.

Three independent studies suggest a way to thwart a mutated gene that drives tumor growth in 95 percent of people with the disease.

The study found that removing nearby lymph nodes didn’t improved survival rates and was associated with serious post-surgical complications.

It’s estimated that more than half of all cancer drugs and antibiotics originated from a chemical compound discovered in a natural product.

Ned Sharpless has been appointed interim head of the regulatory agency after the unexpected resignation of the commissioner.

In two large clinical trials, an immune checkpoint inhibitor combined with a targeted therapy had better outcomes than the standard of care.

Here are some groups and programs to help ease the transition from treatment to survivorship.

The NCI stands to lose nearly $900 million, but childhood cancer would see an increase.

The study “touches on different layers of complexity in cancer development and progression and how to think about better targeting tumors.�...

NCI is expanding eligibility criteria for its cancer clinical trials in the hope that more people will enroll.